Klaviyo (KVYO) to Benefit From Persistent Scaling of Autonomous Engagement Solutions

Klaviyo Incorporated (NYSE:KVYO) is one of the 10 beaten-down technology stocks that could bounce back in 2026.

On February 11, Terry Tillman at Truist reduced the price target on Klaviyo Incorporated (NYSE:KVYO) to $35 from $45 while reaffirming his Buy rating. The analyst informed investors that the company delivered strong fourth-quarter results, with growing enterprise momentum, a record number of ARR customers adding $50K+, and broadening adoption across various products.

Tillman also added that early success with Service and AI-driven Marketing & Customer agents suggests additional upside potential as autonomous engagement solutions continue to scale.

On February 11, Canaccord Genuity reduced the price target on Klaviyo Incorporated (NYSE:KVYO) from $45 to $32. The firm maintained its Buy rating on the shares. Canaccord stated that investor concerns surrounding artificial intelligence are weighing on sentiment, even as the company continues to deliver strong operational results.

Photo by LinkedIn Sales Solutions on Unsplash

Customer growth remains steady, average revenue per user increased by 12%, and momentum with larger clients continues to build. The firm also noted that the introduction of its B2C CRM platform has accelerated expansion opportunities.

Klaviyo Incorporated (NYSE:KVYO) delivers an AI-first SaaS platform for B2C clients that helps in their customer relationship management functions. The platform enables data storage, campaigns, marketing automation, and analytics. It also allows for customer service integration and omni-channel marketing tools such as emails, SMS, and WhatsApp marketing.

While we acknowledge the potential of KVYO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 17 Biotechnology Stocks with More Than 50% Upside and 12 Oversold Financial Stocks to Invest in According to Hedge Funds.